May 5th 2025, 4:00pm
An AI model using serial brain scans predicted glioma recurrence in children with up to 89% accuracy, outperforming single-image methods.
May 5th 2025, 3:00pm
First-line treatment with a Keytruda combo had an overall survival of 17.6 months in some with recurrent/metastatic head and neck squamous cell carcinoma.
May 5th 2025, 1:00pm
In this Q&A, Carly Stafford Dixon discusses her lymphoma journey, recovery with CAR T therapy, and mission to raise support for young adults with cancer.
May 5th 2025, 12:00pm
The phase 3 POIESIS trial is set to investigate navtemadlin as an add-on therapy to Jakafi in patients with JAK inhibitor-naive myelofibrosis.
May 4th 2025, 6:00pm
Dr. Neha Mehta-Shah shares how patients can better understand their subtype of rare lymphoma, as well as expands on the challenges these patients face.
May 4th 2025, 2:00pm
It is with great pride and admiration that I nominate Diane Hudson, RN, OCN, for the Extraordinary Healer Award for Oncology Nursing.
May 3rd 2025, 6:00pm
Dr. Cathy Eng discusses the importance of the Braftovi plus Erbitux FDA approval for treatment-naive BRAF V600E+ metastatic colorectal cancer.
May 3rd 2025, 2:00pm
May 2nd 2025, 9:00pm
The nursing profession is home to countless extraordinary.
May 2nd 2025, 8:00pm
Dr. Scott T. Tagawa discusses what patients with prostate cancer should know about the potential benefits and risks of participating in a clinical trial.
Signatera Guides Bladder Cancer Treatment After Surgery
What If? Embracing Hope During a Cancer Journey
Emerging Treatments and Hopeful Advances in Pancreatic Cancer
FDA Designates MB-105 to Speed Review for Relapsed T-Cell Lymphoma